CVRx Reports Second Quarter 2026 Financial and Operating Results
CVRx, Inc. announced a 16% increase in total revenue for Q2 2026 compared to the prior year, driven primarily by U.S. sales growth and expanded active implanting centers. Despite revenue gains and improved reimbursement policies—including new Medicare Advantage coverage from Humana—the company updated its full-year outlook lower due to fewer sales …